166 related articles for article (PubMed ID: 9552085)
1. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
Rajkumar SV; Gertz MA; Kyle RA
Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085
[TBL] [Abstract][Full Text] [Related]
2. Primary systemic amyloidosis with delayed progression to multiple myeloma.
Rajkumar SV; Gertz MA; Kyle RA
Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
[TBL] [Abstract][Full Text] [Related]
3. [Polyneuropathy is an early finding in primary systemic amyloidosis].
Romi F; Vedeler C; Tysnes OB; Mørk S; Aarli JA
Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1291-3. PubMed ID: 10868089
[TBL] [Abstract][Full Text] [Related]
4. Primary systemic amyloidosis--a diagnostic primer.
Gertz MA; Kyle RA
Mayo Clin Proc; 1989 Dec; 64(12):1505-19. PubMed ID: 2513459
[TBL] [Abstract][Full Text] [Related]
5. Primary amyloidosis presenting as upper limb multiple mononeuropathies.
Tracy JA; Dyck PJ; Dyck PJ
Muscle Nerve; 2010 May; 41(5):710-5. PubMed ID: 20405503
[TBL] [Abstract][Full Text] [Related]
6. Myopathy in primary systemic amyloidosis.
Gertz MA; Kyle RA
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):655-60. PubMed ID: 8648333
[TBL] [Abstract][Full Text] [Related]
7. Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
Loavenbruck AJ; Singer W; Mauermann ML; Sandroni P; B Dyck PJ; Gertz M; Klein CJ; Low PA
Ann Neurol; 2016 Sep; 80(3):401-11. PubMed ID: 27422051
[TBL] [Abstract][Full Text] [Related]
8. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period.
Gertz MA; Kyle RA; Thibodeau SN
Mayo Clin Proc; 1992 May; 67(5):428-40. PubMed ID: 1405768
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic AA amyloidosis manifested by autonomic neuropathy, vestibulocochleopathy, and lattice corneal dystrophy.
Tsunoda I; Awano H; Kayama H; Tsukamoto T; Ueno S; Fujiwara T; Watanabe M; Yamamoto T
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):635-7. PubMed ID: 8201343
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
11. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study.
Mahmood S; Bridoux F; Venner CP; Sachchithanantham S; Gilbertson JA; Rowczenio D; Wagner T; Sayed R; Patel K; Fontana M; Whelan CJ; Lachmann HJ; Hawkins PN; Gillmore JD; Wechalekar AD
Lancet Haematol; 2015 Jun; 2(6):e241-50. PubMed ID: 26688234
[TBL] [Abstract][Full Text] [Related]
12. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.
Ghosh PS; Thaera GM; Tracy JA
Neurology; 2013 Dec; 81(24):e184. PubMed ID: 24323446
[TBL] [Abstract][Full Text] [Related]
13. Amyloidosis: review of 236 cases.
Kyle RA; Bayrd ED
Medicine (Baltimore); 1975 Jul; 54(4):271-99. PubMed ID: 1152671
[TBL] [Abstract][Full Text] [Related]
14. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms.
Matsuda M; Katoh N; Ikeda S
Intern Med; 2014; 53(5):403-12. PubMed ID: 24583427
[TBL] [Abstract][Full Text] [Related]
16. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience.
Cowan AJ; Skinner M; Seldin DC; Berk JL; Lichtenstein DR; O'Hara CJ; Doros G; Sanchorawala V
Haematologica; 2013 Jan; 98(1):141-6. PubMed ID: 22733017
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
18. Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation.
Barsottini OG; Arantes A; Sigulem D; Kutner JM; Ribeiro AA; Moura LA; Hamerschlak N
Arq Neuropsiquiatr; 2004 Sep; 62(3A):725-9. PubMed ID: 15334239
[TBL] [Abstract][Full Text] [Related]
19. Primary AL (kappa-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load: a diagnostic challenge.
Sarkar C; Chand Sharma M; Nayak A; Mercy Ralte A; Gupta V; Singh S; Behari M
Clin Neuropathol; 2005; 24(3):118-25. PubMed ID: 15943163
[TBL] [Abstract][Full Text] [Related]
20. Secondary systemic amyloidosis: response and survival in 64 patients.
Gertz MA; Kyle RA
Medicine (Baltimore); 1991 Jul; 70(4):246-56. PubMed ID: 2067409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
